Patent · US Active

Treatment of immunosuppression-related disorders

US8563307B2 · kind B2 · utility

0Cited by

2References

9Claims

0Family size

Inventors

James Wang · Monterey Park, US
Lufen Chang · Monterey Park, US
Yun Yen · Arcadia, US

Key dates

Filing date	Feb 24, 2009
Grant date	Oct 22, 2013
Priority date	—
Expiry date	Sep 5, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N5/0634
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are methods of using blastomere-like stem cells to (1) decrease the level of myeloid-derived suppressor cells, (2) modulate immune response, (3) overcome a myeloid-derived suppressor cell-mediated immunosuppression, and (4) treat a cellular proliferative disorder. The blastomere-like stem cells, positive for CD66e, can be isolated from blood, bone marrow, or skeletal muscle.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.